NCT03233711 2026-04-13
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
7 trialsNCT00032344 2018-08-31
Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps
VA Office of Research and Development
Phase 3 Completed
NCT00883792 2017-06-19
NordICC
Oslo University Hospital
Phase 3 Active not recruiting
NCT01075633 2014-01-08
COLONFAM
Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Phase 3 Completed
NCT01937429 2013-09-09
GRAND BLEU
Hospices Civils de Lyon
Phase 3 Unknown
NCT01251666 2012-09-03
HeMO
University Hospital, Caen
Phase 3 Completed
NCT01399710 2011-07-22
CAD-IMPACT
im3D S.p.A.
Phase 3 Completed